Investors

banner

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Semler Reports First Quarter 2017 Financial Results
Inventory and Manufacturing Capacity Grow to Prepare for Larger Orders
View HTML
Toggle Summary Semler Reports First Quarter 2018 Financial Results
Profitability Continues SAN JOSE, Calif. , May 1, 2018 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today reported financial results for the three
View HTML
Toggle Summary Semler Reports First Quarter 2019 Financial Results
2019 Q1 HIGHLIGHTS compared to the corresponding period of 2018: - Revenue was $6,761,000, which is an increase of 51% - Net income grew to $0.29 per basic share and $0.23 per diluted share, compared to $0.12 per basic and 0.10 per diluted share - Cash at March 31, 2019 increased to $4,544,000 from
View HTML
Toggle Summary Semler Reports First Quarter 2020 Financial Results
2020 Q1 HIGHLIGHTS compared to the corresponding period of 2019: - Revenues were $9,430,000, which is an increase of 39% - Pre-tax net income of $3,450,000, an increase of $1,596,000, or 86%, compared to $1,854,000 - Net income grew to $0.41 per basic share and $0.33 per diluted share, compared to
View HTML
Toggle Summary Semler Reports First Quarter 2021 Financial Results
2021 Q1 HIGHLIGHTS compared to the corresponding period of 2020: - Revenues were $13.2 million, an increase of 40% - Pre-tax net income of $6.0 million, an increase of $2.5 million, or 74%, compared to $3.5 million - Net income was $4.9 million, or $0.73 per basic share and $0.60 per diluted share,
View HTML
Toggle Summary Semler Reports Fourth Quarter and Annual 2016 Financial Results
Continuing to Increase Market Penetration of its QuantaFlo™ product
View HTML
Toggle Summary Semler Reports Fourth Quarter and Year End 2018 Financial Results
2018 HIGHLIGHTS compared to 2017: - Annual revenue increased by 73% - Net income after tax grew to $0.82 per basic share and $0.66 per diluted share, compared to a net loss of $0.28 per basic and diluted share - All principal and accrued interest on notes were retired - Cash at year-end increased
View HTML
Toggle Summary Semler Reports Fourth Quarter and Yearly 2017 Financial Results
First Quarterly Profit Achieved SAN JOSE, Calif. , Feb. 28, 2018 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today reported financial results for
View HTML
Toggle Summary Semler Reports Record Fourth Quarter and Year End 2019 Financial Results
2019 HIGHLIGHTS compared to 2018: - Annual revenues increased by 52% - Pre-tax income of $10,701,000, an increase of $5,661,000, or 112%, compared to $5,040,000 - Net income after tax grew to $2.34 per basic share and $1.88 per diluted share, compared to $0.82 per basic share and $0.66 per diluted
View HTML
Toggle Summary Semler Reports Record Fourth Quarter and Year End 2020 Financial Results
2020 HIGHLIGHTS compared to 2019: - Annual revenues increased by 18% - Pre-tax net income of $16.5 million, an increase of $5.8 million, or 54%, compared to $10.7 million - Net income of $14.0 million, a decrease of $1.1 million, or 7%, compared to $15.1 million (which included a $4.4 million
View HTML

Semler Scientific

Contact us
Semler Scientific, Inc.
2344 Walsh Avenue
Santa Clara, CA 95051

Call us toll-free at
877-774-4211